NICOLINI, LAURA AMBRA
 Distribuzione geografica
Continente #
EU - Europa 6.706
AS - Asia 803
NA - Nord America 407
SA - Sud America 62
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 7.997
Nazione #
IT - Italia 6.576
US - Stati Uniti d'America 377
SG - Singapore 323
CN - Cina 195
VN - Vietnam 152
FR - Francia 53
BD - Bangladesh 51
BR - Brasile 39
HK - Hong Kong 27
DE - Germania 17
FI - Finlandia 16
CA - Canada 15
IQ - Iraq 10
GB - Regno Unito 9
JP - Giappone 9
AR - Argentina 7
MX - Messico 7
IN - India 6
ES - Italia 5
ID - Indonesia 5
NL - Olanda 5
PH - Filippine 5
RU - Federazione Russa 5
DZ - Algeria 4
EC - Ecuador 4
PY - Paraguay 4
UA - Ucraina 4
CH - Svizzera 3
CL - Cile 3
KE - Kenya 3
PK - Pakistan 3
SA - Arabia Saudita 3
TN - Tunisia 3
UZ - Uzbekistan 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
JM - Giamaica 2
PT - Portogallo 2
AG - Antigua e Barbuda 1
AL - Albania 1
AT - Austria 1
AU - Australia 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CO - Colombia 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
GP - Guadalupe 1
GR - Grecia 1
IR - Iran 1
KG - Kirghizistan 1
KR - Corea 1
KY - Cayman, isole 1
LC - Santa Lucia 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
NG - Nigeria 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
RO - Romania 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
SV - El Salvador 1
TH - Thailandia 1
TR - Turchia 1
TW - Taiwan 1
UY - Uruguay 1
VE - Venezuela 1
Totale 7.997
Città #
Genova 3.356
Genoa 1.926
Rapallo 621
Vado Ligure 577
Singapore 162
San Jose 120
Beijing 46
Lauterbourg 46
Ho Chi Minh City 45
Hanoi 37
Ashburn 27
Bordighera 27
Hong Kong 26
New York 23
Helsinki 16
Council Bluffs 13
Los Angeles 13
Frankfurt am Main 12
Santa Clara 10
Milan 9
Tianjin 8
Tokyo 8
Buffalo 6
Mexico City 5
Orem 5
Atlanta 4
Marseille 4
Montreal 4
Rio de Janeiro 4
Rome 4
Baghdad 3
Biên Hòa 3
Bắc Giang 3
Cardiff 3
Chicago 3
Da Nang 3
Guarulhos 3
Ha Long 3
London 3
Naples 3
Quảng Ngãi 3
Richmond 3
Thái Bình 3
Toronto 3
Tunis 3
Zurich 3
Acalanes Ridge 2
Amsterdam 2
Basra 2
Boardman 2
Bresso 2
Cape Town 2
Charlotte 2
Dallas 2
Des Moines 2
Haiphong 2
Houston 2
Hyderabad 2
Hải Dương 2
Kansas City 2
Kingston 2
Kyiv 2
Madrid 2
Nuremberg 2
Paris 2
Philadelphia 2
Phoenix 2
Quito 2
San Francisco 2
Santa Rosa 2
Santiago 2
Shenzhen 2
São Paulo 2
Tashkent 2
Trieste 2
Verona 2
A Coruña 1
Abidjan 1
Anchorage 1
As Samawah 1
Asunción 1
Athens 1
Atkinson 1
Augusta 1
Avellaneda 1
Açailândia 1
Bab Ezzouar 1
Bari 1
Basingstoke 1
Bedford 1
Belford Roxo 1
Bernay 1
Birmingham 1
Bishkek 1
Boise 1
Bordj el Kiffan 1
Brandon 1
Bremen 1
Brescia 1
Bridgeport 1
Totale 7.296
Nome #
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 330
Budget impact analysis of sofosbuvir-based regimens for the treatment of HIV/HCV-coinfected patients in northern Italy: A multicenter regional simulation 223
Evaluation of insulin resistance in a cohort of HIV-infected youth. 207
Epidemiological and clinical features of hepatitis delta in HBsAg-positive patients by HIV status. 202
Implementing TB control in a rural, resource-limited setting: The stop-TB Italia project in Senegal 202
Effectiveness of a project to prevent HIV vertical transmission in the Republic of Congo. 195
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy 193
Cost per care of the first year of direct antiviral agents in the liguria region: A multicenter analysis 191
Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy 177
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 177
Hepatitis B Virus Vaccination in HIV: Immunogenicity and Persistence of Seroprotection up to 7 Years Following a Primary Immunization Course 176
Hepatitis B reactivation in HBsAg-negative/HBcAb-positive allogeneic haematopoietic stem cell transplant recipients: risk factors and outcome. 173
Drug treatment for multidrug-resistant Acinetobacter baumannii infections 173
Coinfection with HIV and hepatitis C virus in 229 children and young adults living in Europe 171
Efficacy of lamivudine prophylaxis in preventing hepatitis B virus reactivation in patients with resolved infection undergoing allogeneic SCT and receiving rituximab 168
Weight gain: A possible side effect of all antiretrovirals 161
Current status of newer carbapenems 157
A global view to HBV chronic infection: Evolving strategies for diagnosis, treatment and prevention in immunocompetent individuals 156
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients 156
Liver Enzyme Elevation During Darunavir-Based Antiretroviral Treatment in HIV-1-Infected Patients With or Without Hepatitis C Coinfection: Data from the ICONA Foundation Cohort. 156
Successful recovery of associated interstitial nephritis and focal segmental glomerulosclerosis in patients with HCV and HIV treated with sofosbuvir and daclatasvir and revision of literature 156
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA) 154
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program 149
Control of the HIV-1 DNA reservoir is associated in vivo and in vitro with NKp46/NKp30 (CD335 CD337) inducibility and interferon gamma production by transcriptionally unique NK cells 149
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia 149
Correction to: Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy (Infection, 10.1007/s15010-017-1063-7) 148
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? 147
Visceral leishmaniasis in hematopoietic cell transplantation: Case report and review of the literature 144
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 143
Ligurian Vaccination in HIV Program (LIV in HIV): the experience of Genoa metropolitan area 142
CD8+CD28-CD127loCD39+Treg Expansion: a New Pathogenic Mechanism for HIV Infection? 141
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 141
Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing? 137
Tigecycline use in serious nosocomial infections: a drug use evaluation. 136
Nevirapine-based regimens in routine clinical settings: results from a large Italian cohort of HIV-1 infected adults. 132
Role of [18F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography for Diagnosis and Treatment of Sarcoidosis in an HIV-2-Infected Patient. 129
Management of chronic viral hepatitis in the hematological patient 127
Genetic polymorphisms of IL28b gene as predictors of response to dual therapy in genotypes 1 and 4-HCV and HIV/HCV-infected patients 126
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome 121
Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens 119
Incidence of candidaemia and relationship with flucanazole use in an intensive care unit 115
Optimal efficacy of interferon-free HCV retreatment after protease inhibitor failure in real life 114
Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: A multicentre independent study supported by the Italian Drug Agency 109
Fulminant Hepatitis Associated with Echovirus 25 during Treatment with Ocrelizumab for Multiple Sclerosis 102
Barriers to HCV micro-elimination in a cohort of people living with HIV (PLWH) 101
Therapeutic management of chronic hepatitis B in clinical Practice: a region-wide survey. 100
The efficacy of the new anti HCV therapy, implementation of a path based on the logic of micro-elimination in the Department of Mental Health and Addictions ASL4 Chiavarese 98
Long course of daptomycin in the treatment of meticillin-resistant Staphylococcus epidermis endocarditis and spondylodiscitis 96
Rs12979860 and rs8099917 single nucleotide polymorphisms of interleukin-28B gene: simultaneous genotyping in caucasian patients infected with hepatitis C virus. 89
Comments on “Real-world re-treatment outcomes of direct-acting antiviral therapy failure in patients with chronic hepatitis C” 89
Neutralizing monoclonal antibodies for the prevention of severe COVID-19: a retrospective study during Omicron BA.1 variant surge 87
Effectiveness of first-generation HCV protease inhibitors: does HIV coinfection still play a role? 82
Ten Years of Medical Informatics and Standards Support for Clinical Research in an Infectious Diseases Network 81
Insights on common vaccinations in HIV-infection: efficacy and safety 78
Phalangeal quantitative ultrasound: cheaper methods for screening and follow-up of bone pathologies in HIV-infected women? 71
Efficacy, safety and feasibility of treatment of chronic HCV infection with directly acting agents in hematopoietic stem cell transplant recipients – Study of infectious diseases working party of EBMT 69
Prevalence and Risk Factors for Significant Liver Fibrosis in Patients with HIV Infection 66
HCV treatment in children and young adults with HIV/HCV co-infection in Europe 62
null 31
Totale 8.174
Categoria #
all - tutte 27.287
article - articoli 26.573
book - libri 0
conference - conferenze 714
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.574


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202154 0 0 0 0 0 0 0 0 0 0 0 54
2021/2022629 28 19 34 78 25 62 23 140 54 72 24 70
2022/2023743 68 65 6 77 97 106 9 50 112 57 88 8
2023/2024430 12 51 5 50 36 92 36 34 25 8 38 43
2024/20251.378 30 91 27 122 190 150 143 229 60 56 119 161
2025/20262.108 261 56 205 131 294 163 297 93 171 222 152 63
Totale 8.174